Topiramate Solution
Product Images NDC 67877-833

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 67877-833). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ascend Laboratories, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Topi-fig-1 (Topi Fig 1)

A line graph showing cumulative rates for time to first seizure over a period of up to 500 days. It compares two groups receiving Topiramate at dosages of 50 mg/day and 400 mg/day, with sample sizes of 234 and 236 respectively. The graph plots cumulative rates on the vertical axis against time in days on the horizontal axis, indicating differences between dosage groups.*

FDA Label Image

Topi-fig-2 (Topi Fig 2)

A bar chart comparing the change from baseline to double-blind phase in average monthly migraine period rate across placebo and three Topiramate dosages (50 mg/day, 100 mg/day, and 200 mg/day) from two studies (Study 11 and Study 12). The chart shows decreasing migraine rates with increasing Topiramate dose, with statistically significant differences marked at various dose levels.*

FDA Label Image

Topiramate 240 mL Carton Label (Topi Fig 4)

Topiramate Oral Solution 25 mg/mL carton label from Ascend Laboratories, LLC. The label indicates the product is for oral use only, with a 240 mL bottle size. It includes storage instructions, dosing warnings, and pharmacy dispensing guidance, emphasizing the use of an oral dosing syringe and medication guide. The label features the NDC 67877-833-67 and manufacturer information for Alkem Laboratories Ltd., Mumbai, India.*

FDA Label Image

Topi-stru (Topi Stru)

Chemical structure of topiramate, showing its ring system and attached functional groups consistent with the medication topiramate.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.